Intellia Therapeutics, Inc.

LSE:0JBU Stock Report

Market Cap: US$2.0b

Intellia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

LSE:0JBU Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Mar 24SellUS$19,959Eliana ClarkIndividual605US$32.99
04 Mar 24SellUS$75,778James BastaIndividual2,297US$32.99
03 Jan 24SellUS$114,216Derek HicksIndividual3,877US$29.46
03 Jan 24SellUS$158,053Glenn GoddardIndividual5,365US$29.46
03 Jan 24SellUS$162,973Laura Sepp-LorenzinoIndividual5,532US$29.46
03 Jan 24SellUS$172,135David LebwohlIndividual5,843US$29.46
03 Jan 24SellUS$566,310John LeonardIndividual19,223US$29.46
03 Jan 24SellUS$112,095James BastaIndividual3,805US$29.46
03 Jan 24SellUS$135,954Eliana ClarkIndividual4,608US$30.12
03 Jul 23SellUS$14,584Eliana ClarkIndividual360US$40.51

Insider Trading Volume

Insider Buying: 0JBU insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0JBU?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,6570.00379%
Individual Insiders1,175,1841.22%
General Public12,686,88813.2%
Institutions82,572,87985.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.4%.


Top Shareholders

Top 25 shareholders own 66.15% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
ARK Investment Management LLC
10,989,282US$228.1m-3.71%1.82%
9.34%
BlackRock, Inc.
9,010,695US$187.1m10.8%no data
8.66%
The Vanguard Group, Inc.
8,347,449US$173.3m1.9%no data
4.91%
State Street Global Advisors, Inc.
4,735,861US$98.3m26.9%no data
3.52%
Nikko Asset Management Co., Ltd.
3,399,318US$70.6m-2.28%0.03%
2.55%
Wellington Management Group LLP
2,456,917US$51.0m-7.36%0.01%
2.33%
Deep Track Capital, LP
2,250,000US$46.7m12.5%1.67%
2.09%
Federated Hermes, Inc.
2,016,300US$41.9m13.8%0.12%
2.05%
Geode Capital Management, LLC
1,973,269US$41.0m4.95%no data
1.9%
T. Rowe Price Group, Inc.
1,834,143US$38.1m-10.5%no data
1.73%
AllianceBernstein L.P.
1,663,742US$34.5m7.54%0.01%
1.52%
Rokos Capital Management LLP
1,463,630US$30.4m5.35%0.93%
1.5%
Casdin Capital, LLC
1,450,000US$30.1m23.1%2.7%
1.44%
Morgan Stanley, Investment Banking and Brokerage Investments
1,387,907US$28.8m21.8%no data
1.31%
Citadel Advisors LLC
1,259,292US$26.1m-36.1%0.03%
1.23%
FMR LLC
1,185,999US$24.6m-20.5%no data
1.21%
Dimensional Fund Advisors LP
1,170,829US$24.3m5.47%no data
1.07%
Himension Capital (Singapore) Pte Ltd
1,030,621US$21.4m-10%1.72%
1.03%
Chevy Chase Trust Company
991,175US$20.6m-1.17%0.07%
1.02%
Morgan Stanley Investment Management Inc.
980,108US$20.3m-47.3%0.01%
0.92%
Marshall Wace LLP
890,498US$18.5m0%0.04%
0.92%
Northern Trust Global Investments
886,388US$18.4m-3.69%no data
0.92%
Pictet Asset Management Limited
883,470US$18.3m-5.74%0.01%
0.86%
John Leonard
830,546US$17.2m4.09%no data
0.73%
UBS Asset Management AG
706,536US$14.7m33%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.